nodes	percent_of_prediction	percent_of_DWPC	metapath
Dapagliflozin—SLC5A4—Carbohydrate metabolism—FMOD—osteoarthritis	0.0488	0.0488	CbGpPWpGaD
Dapagliflozin—UGT2B4—Phase II conjugation—GSTO1—osteoarthritis	0.0389	0.0389	CbGpPWpGaD
Dapagliflozin—SLC5A1—Carbohydrate metabolism—FMOD—osteoarthritis	0.037	0.037	CbGpPWpGaD
Dapagliflozin—SLC5A2—Carbohydrate metabolism—FMOD—osteoarthritis	0.037	0.037	CbGpPWpGaD
Dapagliflozin—CYP1A1—Tryptophan metabolism—ALDH1A2—osteoarthritis	0.0334	0.0334	CbGpPWpGaD
Dapagliflozin—SLC5A4—Carbohydrate metabolism—BGN—osteoarthritis	0.0271	0.0271	CbGpPWpGaD
Dapagliflozin—UGT2B4—Biological oxidations—GSTO1—osteoarthritis	0.0227	0.0227	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metapathway biotransformation—GSTO1—osteoarthritis	0.0224	0.0224	CbGpPWpGaD
Dapagliflozin—CYP1A2—Tryptophan metabolism—ALDH1A2—osteoarthritis	0.0213	0.0213	CbGpPWpGaD
Dapagliflozin—SLC5A2—Carbohydrate metabolism—BGN—osteoarthritis	0.0206	0.0206	CbGpPWpGaD
Dapagliflozin—SLC5A1—Carbohydrate metabolism—BGN—osteoarthritis	0.0206	0.0206	CbGpPWpGaD
Dapagliflozin—CYP1A1—Arachidonic acid metabolism—PTGES—osteoarthritis	0.0184	0.0184	CbGpPWpGaD
Dapagliflozin—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—osteoarthritis	0.0182	0.0182	CbGpPWpGaD
Dapagliflozin—UGT2B7—Phase II conjugation—GSTO1—osteoarthritis	0.0177	0.0177	CbGpPWpGaD
Dapagliflozin—CYP3A4—Tryptophan metabolism—ALDH1A2—osteoarthritis	0.0165	0.0165	CbGpPWpGaD
Dapagliflozin—CYP1A1—Estrogen Receptor Pathway—ESR1—osteoarthritis	0.0148	0.0148	CbGpPWpGaD
Dapagliflozin—UGT1A9—Phase II conjugation—GSTO1—osteoarthritis	0.0144	0.0144	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—FMOD—osteoarthritis	0.0138	0.0138	CbGpPWpGaD
Dapagliflozin—CYP2C9—Arachidonic acid metabolism—PTGES—osteoarthritis	0.0138	0.0138	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—IHH—osteoarthritis	0.0123	0.0123	CbGpPWpGaD
Dapagliflozin—SLC5A11—NRF2 pathway—TGFB1—osteoarthritis	0.0122	0.0122	CbGpPWpGaD
Dapagliflozin—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—osteoarthritis	0.0121	0.0121	CbGpPWpGaD
Dapagliflozin—CYP1A2—Arachidonic acid metabolism—PTGES—osteoarthritis	0.0118	0.0118	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—FMOD—osteoarthritis	0.0116	0.0116	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—FMOD—osteoarthritis	0.0105	0.0105	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—FMOD—osteoarthritis	0.0105	0.0105	CbGpPWpGaD
Dapagliflozin—UGT2B7—Biological oxidations—GSTO1—osteoarthritis	0.0104	0.0104	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metapathway biotransformation—GSTO1—osteoarthritis	0.0102	0.0102	CbGpPWpGaD
Dapagliflozin—CYP1A2—Estrogen Receptor Pathway—ESR1—osteoarthritis	0.00944	0.00944	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—PTGES—osteoarthritis	0.00943	0.00943	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—IHH—osteoarthritis	0.00933	0.00933	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—IHH—osteoarthritis	0.00933	0.00933	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—TGFBI—osteoarthritis	0.00918	0.00918	CbGpPWpGaD
Dapagliflozin—SLC5A4—NRF2 pathway—TGFB1—osteoarthritis	0.00892	0.00892	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—FMOD—osteoarthritis	0.00877	0.00877	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—FMOD—osteoarthritis	0.00877	0.00877	CbGpPWpGaD
Dapagliflozin—UGT1A9—Biological oxidations—GSTO1—osteoarthritis	0.00842	0.00842	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metapathway biotransformation—GSTO1—osteoarthritis	0.0083	0.0083	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—GSTO1—osteoarthritis	0.00794	0.00794	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—BGN—osteoarthritis	0.00769	0.00769	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—PTGES—osteoarthritis	0.00715	0.00715	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—PTGES—osteoarthritis	0.00715	0.00715	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—TGFBI—osteoarthritis	0.00696	0.00696	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—TGFBI—osteoarthritis	0.00696	0.00696	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—FMOD—osteoarthritis	0.00677	0.00677	CbGpPWpGaD
Dapagliflozin—SLC5A1—NRF2 pathway—TGFB1—osteoarthritis	0.00676	0.00676	CbGpPWpGaD
Dapagliflozin—SLC5A2—NRF2 pathway—TGFB1—osteoarthritis	0.00676	0.00676	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—GSTO1—osteoarthritis	0.00665	0.00665	CbGpPWpGaD
Dapagliflozin—CYP2A6—Biological oxidations—GSTO1—osteoarthritis	0.00649	0.00649	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—BGN—osteoarthritis	0.00644	0.00644	CbGpPWpGaD
Dapagliflozin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoarthritis	0.00626	0.00626	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—GSTO1—osteoarthritis	0.00601	0.00601	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—GSTO1—osteoarthritis	0.00601	0.00601	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—BGN—osteoarthritis	0.00582	0.00582	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—BGN—osteoarthritis	0.00582	0.00582	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—PTGES—osteoarthritis	0.00552	0.00552	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor—ESR1—osteoarthritis	0.00539	0.00539	CbGpPWpGaD
Dapagliflozin—CYP1A2—Phase II conjugation—GSTO1—osteoarthritis	0.00527	0.00527	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—GSTO1—osteoarthritis	0.00504	0.00504	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—GSTO1—osteoarthritis	0.00504	0.00504	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—BGN—osteoarthritis	0.00488	0.00488	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—BGN—osteoarthritis	0.00488	0.00488	CbGpPWpGaD
Dapagliflozin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoarthritis	0.00487	0.00487	CbGpPWpGaD
Dapagliflozin—CYP1A1—Biological oxidations—GSTO1—osteoarthritis	0.00483	0.00483	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metapathway biotransformation—GSTO1—osteoarthritis	0.00477	0.00477	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.00459	0.00459	CbGpPWpGaD
Dapagliflozin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—osteoarthritis	0.00454	0.00454	CbGpPWpGaD
Dapagliflozin—ABCB1—HIF-1-alpha transcription factor network—SMAD3—osteoarthritis	0.00395	0.00395	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—GSTO1—osteoarthritis	0.00389	0.00389	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—osteoarthritis	0.00387	0.00387	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—SMAD3—osteoarthritis	0.00377	0.00377	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—BGN—osteoarthritis	0.00377	0.00377	CbGpPWpGaD
Dapagliflozin—CYP2D6—Biological oxidations—GSTO1—osteoarthritis	0.00364	0.00364	CbGpPWpGaD
Dapagliflozin—CYP1A1—Arachidonic acid metabolism—PTGS2—osteoarthritis	0.00362	0.00362	CbGpPWpGaD
Dapagliflozin—CYP2C9—Biological oxidations—GSTO1—osteoarthritis	0.00361	0.00361	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoarthritis	0.0036	0.0036	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metapathway biotransformation—GSTO1—osteoarthritis	0.00359	0.00359	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—IL1A—osteoarthritis	0.00357	0.00357	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metapathway biotransformation—GSTO1—osteoarthritis	0.00356	0.00356	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—osteoarthritis	0.00343	0.00343	CbGpPWpGaD
Dapagliflozin—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoarthritis	0.00338	0.00338	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—FMOD—osteoarthritis	0.00308	0.00308	CbGpPWpGaD
Dapagliflozin—CYP1A2—Biological oxidations—GSTO1—osteoarthritis	0.00308	0.00308	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metapathway biotransformation—GSTO1—osteoarthritis	0.00304	0.00304	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—SMAD3—osteoarthritis	0.00286	0.00286	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—SMAD3—osteoarthritis	0.00286	0.00286	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoarthritis	0.00279	0.00279	CbGpPWpGaD
Dapagliflozin—CYP2C9—Arachidonic acid metabolism—PTGS2—osteoarthritis	0.0027	0.0027	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.00263	0.00263	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—osteoarthritis	0.00261	0.00261	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor—TNF—osteoarthritis	0.00261	0.00261	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—PTGES—osteoarthritis	0.00251	0.00251	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—FMOD—osteoarthritis	0.00251	0.00251	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—osteoarthritis	0.00246	0.00246	CbGpPWpGaD
Dapagliflozin—CYP3A4—Biological oxidations—GSTO1—osteoarthritis	0.00238	0.00238	CbGpPWpGaD
Dapagliflozin—UGT2B7—NRF2 pathway—TGFB1—osteoarthritis	0.00238	0.00238	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metapathway biotransformation—GSTO1—osteoarthritis	0.00235	0.00235	CbGpPWpGaD
Dapagliflozin—CYP1A2—Arachidonic acid metabolism—PTGS2—osteoarthritis	0.00231	0.00231	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoarthritis	0.00229	0.00229	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—PTGS2—osteoarthritis	0.00221	0.00221	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—PTGES—osteoarthritis	0.00204	0.00204	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.00197	0.00197	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—CXCL8—osteoarthritis	0.00194	0.00194	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—FMOD—osteoarthritis	0.00193	0.00193	CbGpPWpGaD
Dapagliflozin—UGT1A9—NRF2 pathway—TGFB1—osteoarthritis	0.00193	0.00193	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—IL1B—osteoarthritis	0.00186	0.00186	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—PTGS2—osteoarthritis	0.00185	0.00185	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoarthritis	0.00178	0.00178	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—GSTO1—osteoarthritis	0.00177	0.00177	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—BGN—osteoarthritis	0.00172	0.00172	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.00168	0.00168	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—PTGS2—osteoarthritis	0.00167	0.00167	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—PTGS2—osteoarthritis	0.00167	0.00167	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoarthritis	0.00166	0.00166	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoarthritis	0.00166	0.00166	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—TGFB1—osteoarthritis	0.0016	0.0016	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PTGES—osteoarthritis	0.00157	0.00157	CbGpPWpGaD
Dapagliflozin—CYP2A6—NRF2 pathway—TGFB1—osteoarthritis	0.00149	0.00149	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—TGFB1—osteoarthritis	0.00145	0.00145	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—FMOD—osteoarthritis	0.00144	0.00144	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—GSTO1—osteoarthritis	0.00144	0.00144	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—PTGS2—osteoarthritis	0.0014	0.0014	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—PTGS2—osteoarthritis	0.0014	0.0014	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—BGN—osteoarthritis	0.00139	0.00139	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	0.00138	0.00138	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—TNF—osteoarthritis	0.00135	0.00135	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—TGFB1—osteoarthritis	0.00121	0.00121	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—TGFB1—osteoarthritis	0.00121	0.00121	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—IL6—osteoarthritis	0.0012	0.0012	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	0.00119	0.00119	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PTGES—osteoarthritis	0.00117	0.00117	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—FMOD—osteoarthritis	0.00115	0.00115	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—GSTO1—osteoarthritis	0.00111	0.00111	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—FMOD—osteoarthritis	0.00108	0.00108	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—PTGS2—osteoarthritis	0.00108	0.00108	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—BGN—osteoarthritis	0.00107	0.00107	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—FMOD—osteoarthritis	0.00107	0.00107	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	0.000989	0.000989	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PTGES—osteoarthritis	0.000937	0.000937	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—FMOD—osteoarthritis	0.000918	0.000918	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—IL6—osteoarthritis	0.000912	0.000912	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—IL6—osteoarthritis	0.000912	0.000912	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.0009	0.0009	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PTGES—osteoarthritis	0.000883	0.000883	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PTGES—osteoarthritis	0.000875	0.000875	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—GSTO1—osteoarthritis	0.000827	0.000827	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—BGN—osteoarthritis	0.000801	0.000801	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PTGES—osteoarthritis	0.000748	0.000748	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	0.000715	0.000715	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—FMOD—osteoarthritis	0.000708	0.000708	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	0.000667	0.000667	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—GSTO1—osteoarthritis	0.00066	0.00066	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—BGN—osteoarthritis	0.000639	0.000639	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—GSTO1—osteoarthritis	0.000622	0.000622	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—GSTO1—osteoarthritis	0.000617	0.000617	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—BGN—osteoarthritis	0.000603	0.000603	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—BGN—osteoarthritis	0.000597	0.000597	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PTGES—osteoarthritis	0.000577	0.000577	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GSTO1—osteoarthritis	0.000527	0.000527	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.000517	0.000517	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—BGN—osteoarthritis	0.00051	0.00051	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—PTGS2—osteoarthritis	0.000493	0.000493	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GSTO1—osteoarthritis	0.000407	0.000407	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—PTGS2—osteoarthritis	0.000401	0.000401	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—BGN—osteoarthritis	0.000394	0.000394	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.000386	0.000386	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.00033	0.00033	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PTGS2—osteoarthritis	0.000309	0.000309	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PTGS2—osteoarthritis	0.00023	0.00023	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PTGS2—osteoarthritis	0.000184	0.000184	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PTGS2—osteoarthritis	0.000173	0.000173	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PTGS2—osteoarthritis	0.000172	0.000172	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PTGS2—osteoarthritis	0.000147	0.000147	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PTGS2—osteoarthritis	0.000113	0.000113	CbGpPWpGaD
